Monoclonal Antibodies for COVID-19 – An evidence based update
In November of 2020, we discussed the first clinical data for the Monoclonal Antibodies Bamlanivimab and Regenergon (mAb). For a refresher, you can check out the article here. Since that time, researchers have developed several different versions with varying…